Related Experiment Video
Updated: Jun 8, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Gestational diabetes guidelines in a HAPO world.
Joyce Leary1, David J Pettitt, Lois Jovanovic
1UC Davis Medical Center, Department of Internal Medicine, Sacramento, CA 95817, USA. joyce.leary@ucdmc.ucdavis.edu
Best Practice & Research. Clinical Endocrinology & Metabolism
|September 14, 2010
Summary
New guidelines for gestational diabetes diagnosis recommend universal screening using a 75-g oral glucose tolerance test. These recommendations aim to improve maternal and fetal health outcomes by standardizing diagnosis and treatment.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Public Health
Background:
- Gestational diabetes mellitus (GDM) significantly impacts maternal and fetal health.
- Existing diagnostic guidelines lack universal consensus, leading to varied clinical practices.
- The Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study confirmed links between maternal hyperglycemia and adverse perinatal outcomes.
Purpose of the Study:
- To present new guidelines for screening and diagnosing diabetes in pregnancy.
- To establish standardized diagnostic thresholds based on recent research findings.
- To address the need for a unified approach to managing maternal hyperglycemia.
Main Methods:
- Incorporation of findings from the HAPO study and randomized controlled trials.
- Recommendation for universal screening at 24-28 weeks' gestation using a 75-g oral glucose tolerance test (OGTT).
- Establishment of specific glucose concentration thresholds for diagnosis, considering adverse outcome risks.
Main Results:
- Proposed universal screening for GDM using a 75-g OGTT.
- Defined diagnostic thresholds based on fasting, 1-hour, and 2-hour plasma glucose levels.
- Guidelines aim to identify hyperglycemia associated with increased risks of adverse perinatal outcomes.
Conclusions:
- The new International Association of Diabetes and Pregnancy Study Groups (IADPSG) guidelines offer a standardized approach to GDM diagnosis.
- These guidelines are expected to advance the discussion and practice of GDM screening and management.
- Potential challenges include differing opinions on screening strategies and the need for long-term cost-effectiveness data.
More Related Videos
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...